Medication

FILE - This is an April 26, 2017, file photo showing Eli Lilly corporate headquarters in Indianapolis. Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday, Oct. 27, 2020, that It remains confident that its drug may stop COVID from developing in other patients. (AP Photo/Darron Cummings, File)
October 27, 2020 - 5:43 am
INDIANAPOLIS (AP) — Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday it remains confident that its drug may stop COVID from developing in other patients. Researchers are still studying the...
Read More
A bottle containing the drug Remdesivir is held by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary, Thursday Oct. 15, 2020. A large study led by the World Health Organization released on Friday, Oct. 16, 2020, suggests that the antiviral drug did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries. The results do not negate the previous ones, and the WHO study was not as rigorous as the earlier one led by the U.S. National Institutes of Health. But they add to concerns about how much value the pricey drug gives because none of the studies have found it can improve survival. (Zsolt Czegledi/MTI via AP)
October 16, 2020 - 8:46 am
GENEVA (AP) — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries. The results announced...
Read More
President Donald Trump speaks during a campaign rally at Pitt-Greenville Airport, Thursday, Oct. 15, 2020, in Greenville, N.C. (AP Photo/Evan Vucci)
October 15, 2020 - 9:29 pm
WASHINGTON (AP) — President Donald Trump’s plan to mail millions of seniors a $200 prescription savings card has hit legal and budget roadblocks, making it unlikely the government can carry it out before Election Day. Democratic lawmakers have raised questions about whether the administration has...
Read More
This image provided by Regeneron on Wednesday, Oct. 14, 2020, shows a vial of the company's Inmazeb medication. On Wednesday, the U.S. Food and Drug Administration said it has approved the drug for treating Ebola in both adults and children. (Regeneron via AP)
October 14, 2020 - 5:44 pm
U.S. regulators Wednesday approved the first drug for the treatment of Ebola. The Food and Drug Administration OK'd the drug developed by Regeneron Pharmaceuticals for treating adults and children with the Zaire Ebola virus strain, the most deadly of six known types. It typically kills 60% to 90%...
Read More
FILE - In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. (David Morrison/Eli Lilly via AP)
October 13, 2020 - 1:36 pm
Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly that’s similar to a treatment President Donald Trump recently received. Lilly confirmed Tuesday that the study had been paused “...
Read More
In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, vials are inspected at the company's facilities in New York state, for efforts on an experimental coronavirus antibody drug. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help the immune system eliminate it. (Regeneron via AP)
October 08, 2020 - 10:07 am
WASHINGTON (AP) — They’re not cures and it’s not likely that everyone will be able to get them as President Donald Trump has suggested. But experimental antibody drugs like the one Trump was given are among the most promising therapies being tested for treating and preventing coronavirus infections...
Read More
FILE - In this Aug. 27, 2020, file photo, Wisconsin Gov. Tony Evers speaks during a news conference in Kenosha, Wis. Wisconsin health officials and Gov. Evers announced Wednesday, Oct. 7, 2020, that they've opened a field hospital at the state fairgrounds near Milwaukee as a surge in COVID-19 cases threatens to overwhelm hospitals. Wisconsin has become a hot spot for the disease over the last month, ranking third nationwide this week in daily new cases per capita. (AP Photo/Morry Gash, File)
October 07, 2020 - 12:03 pm
MADISON, Wis. — Wisconsin’s governor has announced a field hospital at the state fairgrounds will open within the next week as a surge in coronavirus cases threatens to overwhelm hospitals. According to the state Department of Health Services, only 16% of the state’s 11,452 hospital beds are...
Read More
FILE - In this Oct. 5, 2020, file photo, President Donald Trump boards Marine One at Walter Reed National Military Medical Center after receiving treatment for coronavirus in Bethesda, Md. Ethics experts say the special treatment Trump received to access an experimental COVID-19 drug raises fairness issues and the public's right to know more about Trump's condition. (AP Photo/Evan Vucci, File)
October 06, 2020 - 11:15 pm
The special treatment President Donald Trump received to access an experimental COVID-19 drug raises fairness issues that start with the flawed health care system many Americans endure and end with the public’s right to know more about his condition, ethics and medical experts say. Regeneron...
Read More
President Donald Trump stands on the balcony outside of the Blue Room as returns to the White House Monday, Oct. 5, 2020, in Washington, after leaving Walter Reed National Military Medical Center, in Bethesda, Md. Trump announced he tested positive for COVID-19 on Oct. 2. (AP Photo/Alex Brandon)
Associated Press
October 05, 2020 - 6:00 pm
BETHESDA, Md. (AP) — President Donald Trump staged a dramatic return to the White House Monday night after leaving the military hospital where he was receiving an unprecedented level of care for COVID-19. He immediately ignited a new controversy by declaring that despite his illness the nation...
Read More
Charles M. Rice, professor of virology at Rockefeller University, poses for a portrait in his laboratory office, Monday, Oct. 5, 2020, in New York. Rice was awarded the Nobel Prize in medicine on Monday for the discovery of the hepatitis C virus along with fellow American Harvey J. Alter and British-born scientist Michael Houghton. (AP Photo/John Minchillo)
October 05, 2020 - 7:46 am
STOCKHOLM (AP) — Americans Harvey J. Alter and Charles M. Rice and British-born scientist Michael Houghton jointly won the Nobel Prize for medicine on Monday for their discovery of the hepatitis C virus, a major source of liver disease that affects millions worldwide. Announcing the prize, the...
Read More

Pages